Cohance Lifesciences
Hyderabad, India· Est.
India‑based CDMO delivering integrated small‑molecule, ADC, and nucleic‑acid manufacturing services.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
India‑based CDMO delivering integrated small‑molecule, ADC, and nucleic‑acid manufacturing services.
OncologyImmunologyGeneticsInfectious Diseases
Technology Platform
Integrated chemistry‑biology platform covering high‑potency API synthesis, TriTene™ ADC conjugation, and GMP‑grade nucleic‑acid manufacturing.
Opportunities
Expanding demand for ADC and oligonucleotide manufacturing offers significant growth, as does leveraging its US facility to serve North American clients.
Risk Factors
Regulatory compliance pressures, capital‑intensive capacity expansion, and competition from larger, globally established CDMOs could constrain margins.
Competitive Landscape
Competes with Lonza, Samsung Biologics, Catalent, and WuXi AppTec; differentiation stems from its integrated ADC/nucleic‑acid platform and strong ESG credentials.